Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 10, Number 3, March 2018, pages 233-239

Assessment of Serum Vitamin B12 Levels and Other Metabolic Parameters in Subjects With Different Values of Bone Mineral Density

Figures

Figure 1.
Figure 1. Linear IGF-1-vitamin B12 correlation: regression lines: (a) subjects with normal bone density; (b) subjects with bone mass reduction.
Figure 2.
Figure 2. Data comparison graph between negative and positive controls in vitamin B12 measurement.
Figure 3.
Figure 3. Data comparison graph between negative and positive controls in IGF-1 measurement.
Figure 4.
Figure 4. Data comparison graph between P1NP serum levels in subjects under and over 50 years.
Figure 5.
Figure 5. Data comparison graph between P1NP serum levels in women and men.

Table

Table 1. Comparison and Statistical Significance Between the Two Groups of Subjects in the Study
 
Subject with normal BMDSubject with reduced BMDP value
Sample dimension (n)186 (64.8%)101 (35.2%)
osteopenic (n = 75)
osteoporotic (n = 26)
Average age (years)
Total population		51 ± 12.5456 ± 12.95P = 0.0003 (t-test)
Womenn = 124 (66.6%)
Average age: 51 years
95% CI: 49.33 - 53.36		n = 66 (65.3%)
Average age: 59 years
95% CI: 56.34 - 61.84		P < 0.0001 (t-test)
Menn = 62 (33.3%)
Average age: 49 years
95% CI: 45.47 - 52.76		n = 35 (34.6%)
Average age: 51 years
95% CI: 46.44 - 56.13		P = 0.4724 (t-test)
Vitamine B12 (pg/mL)Mean: 243.91
95% CI: 225.78 - 262.03
SE: 9.19		Mean: 265.15
95% CI: 236.04 - 294.25
SE: 14.67		P = 0.1990 (t-test)
IGF-1 (ng/mL)Mean: 167.34
95% CI: 136.49 - 198.18
SE: 15.64		Mean: 138.79
95% CI: 126.75 - 150.83
SE: 6.07		P < 0.001 (F-test)